Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Targeted Drug Delivery by using Magnetic Nanoparticles
What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...
Targeting the Hypoxic Response in Multiple Myeloma Cells Engrafted in the Bone Marrow
Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody...
Antibiotics and Affect: Avenues for Addiction Management
Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...